Monopteros Therapeutics Overview
- Founded
-
2019
- Status
-
Private
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$20M
- Investors
-
1
Monopteros Therapeutics General Information
Description
Developer of an inhibitor intended to focus on reprogramming of regulatory T-cells. The company works on a treatment to reprogram T-cells in the tumor microenvironment to jump-start an immune attack in cancer patients who otherwise would not respond to checkpoint inhibitors and also provides immunotherapy, which harnesses the power of the immune system to recognize and destroy cancer, enabling cancer patients to have a lasting, life-changing immune response with solid tumors.
Contact Information
Website
monopterostx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 4 Gap Head Road
- Rockport, MA 01966-1908
- United States
Monopteros Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 22-Apr-2021 | $20M | 0000 | 0000 | Completed | Clinical Trials - General |
Monopteros Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
Monopteros Therapeutics Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Arthur DeCillis MD | Chief Medical Officer | ||
| Peter Keller | Chief Executive Officer & Board Member | ||
| Francesco Rubertis Ph.D | Chairman |
Monopteros Therapeutics Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Debasish Roychowdhury MD | Self | Board Member | 000 0000 |
| Francesco Rubertis Ph.D | Self | Chairman | 000 0000 |
| Peter Keller | Self | Chief Executive Officer & Board Member | 000 0000 |
| Shyam Masrani | Self | Board Member | 000 0000 |
| Ulrich von Andrian MD | Monopteros Therapeutics | Board Member | 000 0000 |
Monopteros Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Medicxi | Venture Capital | Minority | 000 0000 | 000000 0 |